pyrroles has been researched along with AIDS-Related Opportunistic Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charman, WN; Hamann, MT; Hammond, NL; Mayer, AM; McIntosh, KA; Peng, J; Wahyuono, S; Yousaf, M | 1 |
Palacios Muñoz, R; Santos González, J | 1 |
Arastéh, K; Hannah, A | 1 |
1 review(s) available for pyrroles and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
Topics: AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; Antiviral Agents; Endothelial Growth Factors; Enzyme Inhibitors; HIV-1; Humans; Indoles; Lymphokines; Neovascularization, Pathologic; Protein Isoforms; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Sarcoma, Kaposi; Skin Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
2 other study(ies) available for pyrroles and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antifungal Agents; Biological Availability; Carbazoles; Carbolines; Fourier Analysis; HIV-1; Indoles; Injections, Intravenous; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Porifera; Pyrroles; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2004 |
[HIV infection: from Pneumocystis to statins].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Atorvastatin; Cardiovascular Diseases; Heptanoic Acids; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pneumocystis Infections; Pyrroles; Risk Factors | 2006 |